Quantitative scintigraphy with deconvolutional analysis for the dynamic measurement of hepatic function.
A mathematical technique known as deconvolutional analysis was used to provide a critical and previously missing element in the computations required to quantitate hepatic function scintigraphically. This computer-assisted technique allowed for the determination of the time required, in minutes, of a labeled bilirubin analog (99mTc-disofenin) to enter the liver via blood and exit via bile. This interval was referred to as the mean transit time (MTT). The critical process provided for by deconvolution is the mathematical simulation of a bolus injection of tracer directly into the afferent blood supply of the liver. The raw data required for this simulation are obtained from the intravenous injection of labeled disofenin, a member of the HIDA family of radiopharmaceuticals. In this study, we perform experiments which document that the simulation process itself is accurate. We then calculate the MTT under a variety of experimental conditions involving progressive hepatic ischemia/reperfusion injury and correlate these results with the results of simultaneously performed BSP determinations and hepatic histology. The experimental group with the most pronounced histologic findings (necrosis, vacuolization, disorganization of hepatic cords) also have the most prolonged MTT and BSP half-life. However, both quantitative imaging and BSP testing are able to identify milder degrees of hepatic ischemic injury not reflected in the histologic evaluation. Quantitative imaging with deconvolutional analysis is a technique easily adaptable to the standard nuclear medicine minicomputer. It provides rapid results and appears to be a sensitive monitor of hepatic functional disturbances resulting from ischemia and reperfusion.
Tagge
E P
EP
Campbell
D A
DA
Reichle
R
R
Averill
D R
DR
Merion
R M
RM
Dafoe
D C
DC
Turcotte
J G
JG
Juni
J E
JE
D000818:Animals; D006321:Heart / Q000000981:diagnostic imaging; D006499:Hepatic Artery; D007098:Imino Acids / Q000008:administration & dosage; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D007511:Ischemia / Q000503:physiopathology; D008099:Liver / Q000098:blood supply / Q000000981:diagnostic imaging*; D008111:Liver Function Tests / Q000379:methods*; D016031:Liver Transplantation; D008432:Mathematical Computing; D009942:Organometallic Compounds / Q000008:administration & dosage; D011169:Portal Vein; D011877:Radionuclide Imaging; D013448:Sulfobromophthalein; D013552:Swine; D013667:Technetium / Q000008:administration & dosage; D019785:Technetium Tc 99m Disofenin
D007098:Imino Acids; D009942:Organometallic Compounds; D013448:Sulfobromophthalein; D013667:Technetium; D019785:Technetium Tc 99m Disofenin